Interview en Vireo CEO Discusses IP And The Possible Future Of Flower Packaging <p><strong>Vireo Health International Inc.&nbsp;</strong>(OTCQX: <a class="ticker" href="">VREOF</a>) has had a busy 2021 so far.</p> <p>The company has had brand expansions, a rollout of its latest IP, and the&nbsp;closing of&nbsp;four medical licenses in Nevada, allowing both medical and adult-use production.</p> <p>The additional expansion also includes February&#39;s nine-acre expansion to its cultivation facility in Arizona. Vireo also opened two additional Green Goods Cannabis centers for patients in Minnesota, bringing its total of opened locations to eight in the state.</p> <p>Vireo CEO Dr. Kyle Kingsley recently spoke to Benzinga about the&nbsp;excitement in Vireo&#39;s five core markets, which&nbsp;have either passed legislation or expect to soon.</p> <p>So far, Arizona has passed legislation while New Mexico, New York, Minnesota, and Maryland all have legislation at some development stage.</p> <p>&quot;That&#39;s a pretty dramatic upside going from these restricted medical markets to full-on adult use,&quot; said Kingsley, calling the possible pivots &quot;remarkable and unusual.&quot;</p> <h4><strong>A Commitment To Tech And IP</strong></h4> <p>The company often touts its dedication to bringing its intellectual ...</p><p><a href= alt=Vireo CEO Discusses IP And The Possible Future Of Flower Packaging>Full story available on</a></p> Cannabis cannabis industry cannabis sales News Penny Stocks premium Vireo VREOF Small Cap Markets Interview VREOF News Penny Stocks Cannabis Small Cap Markets Interview Benzinga Fri, 26 Feb 2021 20:54:23 +0000 Andrew Ward 19859050 at Investors Have Been Flocking To This US Cannabis ETF <p>It only took six months for the newest cannabis ETF to reach $1 billion in assets.</p> <p>On Tuesday, AdvisorShares announced its <strong>AdvisorShares Pure US Cannabis ETF</strong> (NYSE: <a class="ticker" href="">MSOS</a>) crossed the threshold, making it just the second cannabis ETF to reach the mark.</p> <p><strong>ETFMG Alternative Harvest ETF</strong> (NYSE: <a class="ticker" href="">MJ</a>) is the other.&nbsp;</p> <p>MSOS&nbsp;made its debut on Sept. 2 with $2.5 million assets under management. It has since risen 93%.</p> <p>Speaking at the <a href="">Benzinga Cannabis Conference</a> Thursday, AdvisorShares Managing Director and Chief Operating Officer Dan Ahrens said the fund&rsquo;s strong performance and growing popularity have been a direct result of its unique exposure to cannabis.</p> <p>&ldquo;The difference was active management, active stock selection, and U.S. exposure,&rdquo; he said. &ldquo;All ...</p><p><a href= alt=Investors Have Been Flocking To This US Cannabis ETF>Full story available on</a></p> AdvisorShares APHA Cannabis Cannabis Capital Conference CRLBF CURLF Dan Ahrens GTBIF GWPH MJ MSOS multi-state operators News premium TCNNF VFF YOLO Small Cap Events Markets Interview General GWPH VFF MJ GTBIF TCNNF YOLO APHA CURLF CRLBF MSOS News Cannabis Small Cap Events Markets Interview General Benzinga Fri, 26 Feb 2021 15:04:07 +0000 Spencer Israel 19869880 at HempFusion's Ola Lessard Discusses America's Hemp Potential, Ongoing Advocacy Efforts <p><strong>Hempfusion Wellness Inc.&nbsp;</strong>(OTCQX: <a class="ticker" href="">CBDHF</a>) Chief Marketing Officer Ola Lessard&nbsp;juggles&nbsp;several roles in the emerging hemp space. In addition to being CMO, and overseeing&nbsp;several large-scale endeavors for a company that recently&nbsp;<a href="">went public</a>, she&nbsp;was also re-elected as president of the non-profit U.S. Hemp Roundtable <a href="">earlier this month</a>.</p> <p>Lessard is also the first woman to head the group and the first person to earn a second term. The&nbsp;advocacy organization aims&nbsp;to advance hemp regulations and diversity in the industry.</p> <h4><strong>Impact Of USDA Rulings On Industry</strong></h4> <p>Lessard&nbsp;credits the Hemp Roundtable&#39;s dedication for staying abreast of a seemingly ever-changing space on the federal and state levels.</p> <p>Lessard believes that the industry can find happiness in the USDA&#39;s final rules issued for hemp, highlighting more flexibility for hot hemp disposal.</p> <p>&quot;Some progress&quot; was made on testing, Lessard&nbsp;told ...</p><p><a href= alt=HempFusion&#039;s Ola Lessard Discusses America&#039;s Hemp Potential, Ongoing Advocacy Efforts>Full story available on</a></p> Cannabis CBDHF Hemp Hemp Roundtable Hempfusion Wellness Inc M&A News Penny Stocks premium Guidance Markets Interview CBDHF News M&A Penny Stocks Cannabis Guidance Markets Interview Benzinga Fri, 26 Feb 2021 14:50:25 +0000 Andrew Ward 19858936 at How Advisors Should Plan Virtual Events <p><em>In the latest of That Makes Cents, an eMoney Advisor podcast powered by Benzinga, we spoke with Daniel Pelesko, eMoney&rsquo;s events manager, and Greg Furer, CEO of Beratung Advisors.</em></p> <p>It&rsquo;s been about 11 months since the pandemic started to have an impact here in the U.S. and by now we&rsquo;ve all either attended or at the very least been invited to&nbsp;a virtual event.&nbsp;</p> <p>Even after life returns to normal, it&rsquo;s unlikely that virtual events will go away entirely.&nbsp;</p> <p>In other words, advisors who want to plan events&mdash;be it for their clients or other advisors&mdash;will need to adjust, if they haven&rsquo;t already.</p> <p>On this episode of That Makes Cents, we speak ...</p><p><a href= alt=How Advisors Should Plan Virtual Events>Full story available on</a></p> Beratung Advisors Daniel Pelesko eMoney Financial Advisors Greg Furer podcast That Makes Cents virtual events Events Personal Finance Interview General Financial Advisors Events Personal Finance Interview General Benzinga Fri, 26 Feb 2021 14:49:08 +0000 Spencer Israel 19876777 at Kevin O'Leary Of 'Shark Tank,' Benzinga CEO Jason Raznick Talk GameStop, Bitcoin And Economic Recovery Trades <p>Benzinga CEO Jason Raznick and O&rsquo;Shares ETF Investments Chairman Kevin O&rsquo;Leary participated in a <a href="">YouTube discussion</a> with O&rsquo;Shares CEO Connor O&rsquo;Brien Thursday, covering topics such as Reddit&rsquo;s WallStreetBets, potential economic recovery trades and the recent volatility in <a href=""><strong>Bitcoin price</strong></a> (Crypto: BTC) and other cryptocurrencies.</p> <p><strong>WallStreetBets:</strong> Raznick discussed the crazy trading action in <strong>GameStop Corp.</strong> (NYSE: <a class="ticker" href="">GME</a>) and Benzinga&rsquo;s coverage of the surreal story behind the volatility on its live YouTube channel.</p> <p><em>Related Link: <a href="">GameStop Drama Continues: Soaring Stock Halted, Cramer, Citron Weigh In</a> </em></p> <p>&ldquo;Obviously the WallStreetBetters were behind this for a while, but the day Andrew Left from Citron Research was going public about [his short thesis], his Twitter video wasn&rsquo;t working. He came <a href="">live on our show</a> when we had 600 viewers on our show. Within 8 minutes, the WallStreetBets guys showed up. We had 13,000 to 15,000 people in there going crazy,&rdquo; Raznick said.</p> <p>Within an hour-and-a-half of Left&#39;s Jan. 21 Benzinga&nbsp;interview, GameStop shares had skyrocketed from $41 to $80.</p> <p>&ldquo;They were calling me a boomer because I didn&rsquo;t own the stock, and they were threatening if I didn&rsquo;t buy the stock they were going to thumbs down, unsubscribe. I basically bought 100 shares live on the show because I&rsquo;d never seen anything like it.&rdquo;</p> <p>O&rsquo;Leary said he doesn&rsquo;t believe there will ultimately be much regulatory fallout from the GameStop fiasco.</p> <p>&ldquo;The market actually performed quite well. Short squeezes have happened in the past, they&rsquo;re going to happen in the future,&rdquo; the &quot;Shark ...</p><p><a href= alt=Kevin O&#039;Leary Of &#039;Shark Tank,&#039; Benzinga CEO Jason Raznick Talk GameStop, Bitcoin And Economic Recovery Trades>Full story available on</a></p> $BTC Andrew Left Citron Research Connor O’Brien Cryptocurrency GME HLT Jason Raznick Kevin O’Leary SAVE Short Sellers TSLA Top Stories Markets Media Trading Ideas Interview GME US36467W1099 TSLA US88160R1014 SAVE US8485771021 HLT $BTC Short Sellers Cryptocurrency Top Stories Markets Media Trading Ideas Interview Benzinga Thu, 25 Feb 2021 18:50:55 +0000 Wayne Duggan 19860509 at Fintech Spotlight: OVTLYR Launches Behavioral Analytics Tool For Retail Investors <p><strong><a href="">OVTLYR</a></strong>, an AI-driven behavioral analytics tool for retail investors, formally announced its web-based platform launched for free, as a pilot.</p> <p>As part of the development, Benzinga chatted with co-founders Mark Gorzycki, as well as Mahesh Kashyap.</p> <p><strong>What Happened: </strong>Gorzycki and Kashyap are financial services and behavioral analytics veterans.</p> <p>Alongside the rise in active trading by retail investors, due in part to the commission-free and gamified trading revolution, Gorzycki and Kashyap saw a need for an AI-driven investing platform -- a tool that boils down sentiment into favorable stock entries and exit.</p> <p>&ldquo;Our end goal is how can we make OVTLYR affordable for the masses,&rdquo; Kashyap said. &ldquo;It&rsquo;s not just for traders, it can be for people with busy lives, someone who doesn&rsquo;t want to be very active, but not passive, as well.&rdquo;</p> <p>OVTLYR&rsquo;s behavioral analytics tools, which support over 1,000 of the largest assets by market capitalization, ...</p><p><a href= alt=Fintech Spotlight: OVTLYR Launches Behavioral Analytics Tool For Retail Investors>Full story available on</a></p> AI algorithms Fintech gamestop GME Mahesh Kashyap Mark Gorzycki NLP OVTLYR wallstreetbets Interview GME US36467W1099 Fintech Interview Benzinga Thu, 25 Feb 2021 00:00:22 +0000 Renato Capelj 19814906 at Exclusive: REE Automotive CEO Daniel Barel On What Makes EV Platform Unique <p><strong>REE Automotive</strong> CEO Daniel Barel joined Benzinga&#39;s&nbsp;&quot;<a href="">SPACs Attack</a>&quot; show Wednesday to talk about the company&#39;s path to the Nasdaq, the EV market and more.</p> <p><strong>The SPAC Deal:</strong> In early February, REE Automotive, a leader in eMobility, announced a SPAC deal with <strong>10X Capital Venture Acquisition Corp</strong> (NASDAQ: <a class="ticker" href="">VCVC</a>) to go public.</p> <p>The deal will bring $500 million in gross proceeds to REE Automotive. The deal values REE Automotive at $3.1 billion.</p> <p>Shareholders of 10X Capital Venture Acquisition Corp will own 5.6% of the company if the merger is approved.</p> <p><strong>Barel On Going Public:</strong> Benzinga asked Barel why his company is going public via SPAC.&nbsp;</p> <p>&quot;The reason we decided to go public via SPAC is because you can get much faster to the market, and more importantly, you can choose your running partners,&quot; he said.&nbsp;</p> <p><strong>REE Automotive&#39;s Partnerships: </strong>REE Automotive has been working on partnerships with companies like Mitsubishi and Mahindra &amp; Mahindra.</p> <p>The company has been working on creating a strong partnership foundation, Barel said, adding that it&#39;s&nbsp;very important for the company&#39;s long-term ...</p><p><a href= alt=Exclusive: REE Automotive CEO Daniel Barel On What Makes EV Platform Unique>Full story available on</a></p> electric vehicles News REE Automotive SPAC SPACs VCVC Exclusives Tech Interview VCVC News Exclusives Tech Interview Benzinga Wed, 24 Feb 2021 22:40:09 +0000 Zoltan Suranyi 19836246 at Exclusive: Grayscale CEO 'Wouldn't Rule Out' Future Bitcoin ETF Launch In US <p>Grayscale CEO Michael Sonnenshein said the firm would not rule out launching a <strong>Bitcoin&nbsp;</strong>(Crypto: BTC)&nbsp;ETF in the future if the SEC ever grants approval for such a product.</p> <p>Grayscale&nbsp;operates the first publicly quoted <a href="">Bitcoin</a> investment vehicle via the <strong>Grayscale Bitcoin Trust</strong>&nbsp;(OTCQX: <a class="ticker" href="">GBTC</a>).</p> <p><strong>Sonnenshein On Bitcoin Investments:</strong> While it&#39;s technically not an exchange-traded fund by definition, Grayscale CEO Michael Sonnenshein told Benzinga he believes an eventual ETF launch in the U.S. is likely.&nbsp;</p> <p>&quot;I certainly wouldn&#39;t rule it out,&quot; he said on&nbsp;<a href=";">Benzinga&#39;s PreMarket Prep</a> Wednesday.</p> <p>&quot;I think the important thing to note is that investors aren&#39;t waiting for an ETF. Investors are not sitting on the sidelines and not getting involved in crypto because there isn&#39;t an ETF yet. We&#39;re seeing evermore participation in the market across everything from retail investors all the way to the other end of ...</p><p><a href= alt=Exclusive: Grayscale CEO &#039;Wouldn&#039;t Rule Out&#039; Future Bitcoin ETF Launch In US>Full story available on</a></p> $BTC Bitcoin Cryptocurrency GBTC Grayscale Michael Sonnenshein News PreMarket Prep SQ TSLA Exclusives Markets Interview TSLA US88160R1014 GBTC SQ $BTC News Cryptocurrency Exclusives Markets Interview Benzinga Wed, 24 Feb 2021 19:22:38 +0000 Jayson Derrick 19831137 at Exclusive: Blue Apron's CEO On Why Revenue Growth Is Sustainable 'Even Beyond COVID' <p>Meal kit delivery company <strong>Blue Apron Holdings</strong> (NYSE: <a class="ticker" href="">APRN</a>) recently reported mixed <a href="">fourth-quarter results</a>.</p> <p>A loss of 67 cents per share fell short of the 61-cents-per-share&nbsp;loss expected, while revenue of $115.46 million beat estimates of $110.5&nbsp;million.</p> <p>Following the report, Benzinga had the opportunity to catch up with Blue Apron CEO Linda Findley Kozlowski to recap the fourth quarter and discuss what to expect from the company in 2021.</p> <p><strong>Blue Apron&#39;s Customer Initiatives:</strong> Blue Apron ended its fourth quarter with 353,000 active customers, up from 351,000 last year but down from 357,000 as of the end of September. Meal kit delivery has some seasonality,&nbsp;especially in the fourth quarter, the CEO told Benzinga.</p> <p>Also important to note is that the company acknowledged in its third-quarter earnings report it&#39;s working through challenges in terms of labor availability, and this will impact its ability to address all of the increased demand, she said.&nbsp;</p> <p>The&nbsp;headwinds&nbsp;became&nbsp;&quot;significantly better&quot; throughout the fourth quarter and into the first quarter of the new year, Findley Kozlowski said.</p> <p>Coupled with a compelling lineup of food choices and a refreshed marketing campaign, Blue Apron is focused on increasing the value and engagement of every customer.&nbsp;</p> <p>&quot;We have been focused ...</p><p><a href= alt=Exclusive: Blue Apron&#039;s CEO On Why Revenue Growth Is Sustainable &#039;Even Beyond COVID&#039;>Full story available on</a></p> APRN DIS Earnings food Food Delivery Linda Findley Kozlowski meal kits News Small Cap Management Top Stories Exclusives Interview DIS US2546871060 APRN News Earnings Small Cap Management Top Stories Exclusives Interview Benzinga Wed, 24 Feb 2021 12:40:14 +0000 Jayson Derrick 19804257 at Premium: NBA Legend Chris Webber's $100M PE Fund Offers 'A Seat At The Table' <p>On the heels of launching a $100 million private equity cannabis fund, five-time NBA All-Star Chris Webber and JW Asset Management head Jason Wild spoke to Benzinga to discuss the importance of their endeavor&nbsp;as well as what&#39;s to come in cannabis and beyond.</p> <p>Scroll down to watch the&nbsp;exclusive video.</p> <h4><strong>Aiming For Industry Change</strong></h4> <p>The Webber Wellness brand founder wants&nbsp;a robust cannabis industry that does not leave anyone behind. The effort aims to diversify an industry that currently sees over 80% of its businesses owned by whites.</p> <p>&quot;We&#39;re so encouraged that we get to bring people to a seat at the table,&quot; added Webber.</p> <p><iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="" width="560"></iframe></p> <p>Wild says the past few years opened his eyes to the disparity in cannabis arrests and nascent industry, prompting him to ...</p><p><a href= alt=Premium: NBA Legend Chris Webber&#039;s $100M PE Fund Offers &#039;A Seat At The Table&#039;>Full story available on</a></p> Cannabis cannabis industry Chris Webber Financial Advisors Jason Wild legal weed marijuana NBA News premium private equity Entrepreneurship Financing Success Stories Startups Markets Personal Finance Interview General News Financial Advisors Cannabis Entrepreneurship Financing Success Stories Startups Markets Personal Finance Interview General Benzinga Wed, 24 Feb 2021 11:07:06 +0000 Andrew Ward 19808428 at Exclusive: Vislink CEO Talks IP, 5G And Long-Term Plans <p><strong>Vislink Technologies Inc</strong> (NASDAQ: <a class="ticker" href="">VISL</a>) is a global technology company that specializes in the collection, delivery&nbsp;and management of live video and data. On Tuesday, Vislink CEO Mickey Miller was a guest on Benzinga&#39;s &quot;Power Hour.&quot;</p> <p><strong>&#39;IP Everywhere&#39;:</strong> Miller was appointed as Vislink CEO in January 2020, and in his one year of leadership, the company has launched more products than it did in the previous five years, he&nbsp;said.</p> <p>The company now has &quot;IP everywhere&quot; video is concerned, from IP that has been in the computer world for more than 20 years to contracts with Bosnia&#39;s military, he said.</p> <p>Vislink continues to focus on expanding ...</p><p><a href= alt=Exclusive: Vislink CEO Talks IP, 5G And Long-Term Plans>Full story available on</a></p> 5G Mickey Miller News Penny Stocks Power Hour video VISL Small Cap Exclusives Interview VISL News Penny Stocks Small Cap Exclusives Interview Benzinga Tue, 23 Feb 2021 22:16:59 +0000 Jayson Derrick 19804949 at Skye Bioscience Is Pursuing A New Kind Of Glaucoma Drug <p><em>The following article is sponsored by Skye Bioscience, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.</em></p> <p>&nbsp;</p> <p>The beginning of 2021 marked the start of a busy time for cannabinoid biopharmaceutical company <strong>Skye Bioscience, Inc.</strong> (OTC: <a class="ticker" href="">SKYE</a>), not the least of which is the company&#39;s transition from its previous name, Emerald Biosciences, to its new and ambitious imprimatur.</p> <p>&ldquo;I&#39;m excited about this current chapter of the company,&rdquo; explained Skye Bioscience CEO Punit Dhillon in a recent interview with Benzinga. &ldquo;The new name reflects a reset for the company that better represents our goal to be a leader in advancing cannabinoid science.&rdquo;</p> <p>The new year also introduced to the calendar a series of incoming results from pre-clinical and clinical-enabling studies on Skye Bioscience&rsquo;s leading glaucoma drug, which is derived from the company&rsquo;s proprietary modified THC compound. Should the results prove positive, they would pave the way for an Investigational New Drug (IND) application into what is a potentially $7 billion drug category.</p> <p>According to Dhillon, the studies, which are set to conclude over the next 12 months, look to deliver exciting insights into the safety and efficacy of the locally-administered drug in both reducing and regulating intraocular pressure (IOP) as well as a potentially first-in-class mechanism for protecting optic nerve cells.</p> <h3><strong>A New Approach</strong></h3> <p>With its first-in-class THC-derived compound, the team at Skye is hoping to validate superior IOP-lowering relative to other commercially available drugs in humans. Glaucoma affects nearly 80 million people worldwide and is the leading cause of irreversible blindness.</p> <p>&ldquo;Ours is the first and only cannabinoid-derived prodrug designed ...</p><p><a href= alt=Skye Bioscience Is Pursuing A New Kind Of Glaucoma Drug>Full story available on</a></p> Biotech glaucoma Penny Stocks Punit Dhillon SKYE Health Care Interview General SKYE Biotech Penny Stocks Health Care Interview General Benzinga Tue, 23 Feb 2021 14:02:37 +0000 Chris Dier-Scalise 19796885 at Exclusive: New CareDX CEO Reg Seeto Talks Transplantation Care Provider's Mission, Vision, Growth Drivers <p>Benzinga recently spoke with <strong>CareDx Inc</strong> (NASDAQ: <a class="ticker" href="">CDNA</a>) CEO Reginald Seeto to discuss the diagnostics surveillance solution provider&#39;s business, financials, market opportunity, alliances and future focus areas.</p> <p>Seeto, a pharma industry veteran, took over the reins in November from then-CEO Peter Maag, who transitioned to the role of executive chairman to the board.</p> <p>The company is set to report fourth-quarter results after the close Wednesday.</p> <p><strong>BZ:&nbsp;Tell us what CareDx means for the transplant community and give a brief description about its major projects and other business lines.</strong></p> <p><strong>Seeto:</strong> <a href=""> CareDx </a> has been supporting transplant for more than 20 years. We are the largest dedicated transplant company in the U.S. and also in the world. It&#39;s 100% focus is on transplant. In terms of mission, it is how to improve outcomes, and our vision is to be the leader connecting the different parts of the ecosystem.</p> <p>We play a very important role because transplant is an area, historically, where many companies have come in and out, and I think for us we&#39;re absolutely committed to this space and supporting that patient journey.</p> <p>In terms of our product lines, we have what&#39;s called testing services, which includes AlloSure and AlloMap for heart and kidney patients, and we are expanding to other organs. We also have the products business, and the digital business, which comprises&nbsp;various pieces &mdash; the chief among them is the interface with EMR at centers. And the fourth business line is&nbsp;pharma partnerships.</p> <p><strong>BZ: How strong are&nbsp;CareDx&#39;s international operations?</strong></p> <p><strong>Seeto: </strong>For strategic R&amp;D and manufacturing, we have locations in Australia&nbsp;and Sweden.</p> <p>Secondly, we have an [international] commercial presence. Ex-U.S., the largest commercial presence is in Europe, where we have a direct&nbsp;salesforce. We also have a presence in parts of Asia. More importantly, we also rely on distribution partnerships.</p> <p>Overall, the dominant part of our businesses is in the U.S.</p> <p><strong>BZ: How do you explain CareDx&#39;s resilience in the wake of the pandemic?</strong></p> <p><strong>Seeto: </strong> Our entire strategy moves forward by 18 months. Because we had transplant centers and transplant patients in the middle of COVID in March, we were looking for solutions and options as to how patients could continue monitoring their organ grafts and also how to do it in the way which was convenient and appropriate for them.</p> <p>What we were able to do is establish a direct connection with the patient by offering the service called RemoTraC, which is a mobile phlebotomy service, an offering where testing could still be done, but blood drawn at home. We also introduced other things for patients to connect with them, such as our patient app. It was all built around this connectivity with the patient, with the strong support of centers allowing us to do this.</p> <p><strong>BZ: With restrictions easing further, do you see an acceleration in testing volumes?</strong></p> <p><strong>Seeto: </strong> Yes, we have multiple parts of our testing services that will continue to grow.</p> <p>On the kidney side, we are essentially in more than 70% of the&nbsp;centers in the U.S., and we have more than 55 protocols, which continue to grow quarter-on-quarter. And one in three new patients start on Allosure. So, we have a very strong presence in the transplant center.</p> <p>What we&#39;re seeing during the course of 2021 is that we are now moving into the community, and that will allow for further incremental growth.</p> <p>In terms of the heart space, we&#39;re already in 90% of the centers and used in one in two heart transplant patients.</p> <p>What we saw at the end of last year&nbsp;is our multimodality strategy being validated. Having more ...</p><p><a href= alt=Exclusive: New CareDX CEO Reg Seeto Talks Transplantation Care Provider&#039;s Mission, Vision, Growth Drivers>Full story available on</a></p> Allosure Biotech CDNA Covid-19 News Reginald Seeto Health Care Management Top Stories Exclusives Interview General CDNA News Biotech Health Care Management Top Stories Exclusives Interview General Benzinga Tue, 23 Feb 2021 12:50:25 +0000 Shanthi Rexaline 19767404 at 3 Tips For Businesses Looking To Scale In 2021, According To Courtney Lawless <p>When leading, it helps to think about who you&rsquo;re serving and what&rsquo;s the mission.</p> <p>That&rsquo;s according to Courtney Lawless, a venture capitalist, entrepreneur&nbsp;and tech</p> <p>Host of &quot;<a href="">Wolf PAC</a>,&quot; a &quot;Shark Tank&quot; alternative filmed in Philadelphia and released on Amazon Prime, Lawless is highly experienced in business.</p> <p>With 18 years in leadership and business strategy, as well as an extensive background in private equity, venture capital, hedge funds, real estate, and structuring large business deals, Lawless has identified, developed&nbsp;and scaled businesses to their full potential.</p> <p>In a conversation with Benzinga, Lawless spoke about her origins, as well as tips for success in business and raising funds.</p> <p><strong>Origins, Career Progression: </strong>Early on, Lawless was fortunate to have great mentors.</p> <p>&ldquo;Even as a junior, I had a seat at the table, and was able to ask questions and become confident in what I was thinking and saying,&rdquo; she said in a conversation regarding one mentor who had a servant leadership mindset. &ldquo;He was about who we&rsquo;re serving, and realizing that you work for the employee.&rdquo;</p> <p>Those early experiences were integral in Lawless&rsquo;s career progression; she went on to fundraise and market for the middle market, private equity, real estate, and venture funds.</p> <p>&ldquo;I cut my teeth in the fund world,&rdquo; she told Benzinga. &ldquo;Anything from life sciences to consumer goods and the beauty industry.&rdquo;</p> <p>Alongside her efforts to assist businesses of all sizes to execute strategy, Lawless co-owns and manages <a href="">MoxēHub</a>, a software development technology company.</p> <p>&ldquo;We&rsquo;re really focusing on hyper-automation, and how we can remove as much friction as we can from ...</p><p><a href= alt=3 Tips For Businesses Looking To Scale In 2021, According To Courtney Lawless>Full story available on</a></p> Amazon Prime Courtney Lawless entrepreneur MoxēHub ventura capital Wolf PAC Entrepreneurship Movers & Shakers Startups Small Business Exclusives Tech Interview General Entrepreneurship Movers & Shakers Startups Small Business Exclusives Tech Interview General Benzinga Mon, 22 Feb 2021 23:45:26 +0000 Renato Capelj 19664161 at SMG's Hawthorne Launches Social Justice Fund Aimed At Fixing 'War On Drugs' Damage <p class="normal">Hawthorne Gardening Company, a subsidiary of&nbsp;<strong>Scotts Miracle-Gro</strong> (NYSE: <a class="ticker" href="">SMG</a>), recently announced the launch of the Hawthorne Social Justice Fund &mdash;&nbsp;a $2.5 million fund created to support not-for-profit organizations with cannabis social justice missions.</p> <p class="normal">&ldquo;It&rsquo;s obvious that our nation experienced a watershed moment this year in terms of how we think about and discuss social justice. To us, this meant we needed to both look hard at what we&rsquo;re doing and make sure we&rsquo;re doing an adequate job informing our consumers and the industry at large,&rdquo; says Chris Hagedorn, senior vice president and general manager of Hawthorne.</p> <p class="normal"><strong>Social Justice in Mind:</strong> At first, the fund &mdash; managed by the Scotts Miracle-Gro Foundation &mdash; will provide grants focused on addressing the disproportionate level of cannabis arrests and incarcerations among people of color.</p> <p class="normal">&ldquo;The Hawthorne Social Justice Fund within the ...</p><p><a href= alt=SMG&#039;s Hawthorne Launches Social Justice Fund Aimed At Fixing &#039;War On Drugs&#039; Damage>Full story available on</a></p> Cannabis cannabis industry cannabis sales SMG Markets Interview SMG US8101861065 Cannabis Markets Interview Benzinga Mon, 22 Feb 2021 19:31:09 +0000 Benzinga Cannabis 19778643 at